Common questions about Dobendan Strepsils (FAQ)
Q: What is the difference between the standard Dobendan Strepsils and the intense version?
The key difference lies in the active ingredients. Regulatory documents indicate that the standard version often combines a surface antiseptic with a local anesthetic. In contrast, the Intense version typically contains Flurbiprofen, and is classified as an NSAID, a class of drugs used to address inflammation.
Q: How quickly can one expect to feel an effect after using Dobendan Strepsils?
According to official product information, the Flurbiprofen (Intense) lozenge is reported to have an onset of pain relief beginning after approximately 15 minutes of use. The initial numbing effect for the anesthetic versions is intended to be fast-acting, consistent with the local action of an anesthetic.
Q: What is the typical length of time the effects of Dobendan Strepsils last?
For the Flurbiprofen (Intense) formulation, official studies indicate the pain relief effect can last for up to 4 hours. The dosing instructions for all formulations are structured to provide relief over short periods.
Q: Is it safe to use Dobendan Strepsils while driving?
Official regulatory documents for some versions state the product has no or negligible influence on the ability to drive or use machinery. However, the safety profile for the Flurbiprofen version lists side effects such as dizziness as uncommon. If side effects such as dizziness occur, these may potentially affect the ability to drive or operate machinery.
Q: Can patients with high blood pressure use Dobendan Strepsils?
Caution is required for patients with pre-existing hypertension (high blood pressure). Official warnings state that fluid retention and swelling have been reported in association with NSAID therapy, such as that provided by the Flurbiprofen version. Regulatory warnings indicate that caution is required in this population.
Q: If I am pregnant, where can I find official information about using Dobendan Strepsils?
The primary official source is the Patient Information Leaflet (PIL) or the Summary of Product Characteristics (SmPC) for the professional. Regulatory documents state use is generally not recommended in pregnancy, especially in the third trimester, due to potential risk to the fetus.
Q: What should I look for on the product label to ensure I have the right type?
You should check the Active Ingredient list on the package. The main active ingredient determines the product type: look for Flurbiprofen for the Intense version, or the combination of a local anesthetic and antiseptic for the standard lozenge.
Q: Is there a maximum number of days Dobendan Strepsils is typically used?
Official administration instructions recommend that the product should be used for a maximum of 3 days. It is intended for short-term symptomatic relief only. If your symptoms worsen or persist after this time, the patient information advises seeking medical attention.
Q: Can Dobendan Strepsils be taken with food or drink?
The lozenge must be allowed to dissolve slowly in the mouth for proper local action. To prevent interference, regulatory documents for some versions recommend that the lozenge be taken separate from a meal.
Q: What should I do if I accidentally used more Dobendan Strepsils than suggested?
In the event of accidental overuse or overdose, regulatory documents state that medical attention is needed. While symptoms are often mild (like gastrointestinal upset), the Benzocaine component carries a risk of a serious condition called methemoglobinemia if excessive amounts are used.
Q: Does Dobendan Strepsils contain sugar?
Many formulations of Dobendan Strepsils contain sugars like glucose and sucrose, which are listed as excipients. However, sugar-free versions are also available and utilize sweeteners like isomalt and maltitol instead.
Q: Is Dobendan Strepsils considered a systemic medicine or one that acts locally?
The product is primarily formulated for local action on the throat mucosa. Although the Flurbiprofen component is absorbed systemically, the dosage form and indication emphasize its benefit for local symptomatic relief in the throat.
Q: Why do some people experience dry mouth when using lozenges like Dobendan Strepsils?
Dry mouth is listed as an uncommon side effect in the official regulatory profile for the Flurbiprofen lozenge. It is reported less frequently than common side effects like nausea or oral numbness.
Q: Are all the active ingredients fully absorbed into the body?
No. The local anesthetic (Benzocaine) and antiseptic (CPC) components are only minimally absorbed systemically. The Flurbiprofen component, however, is absorbed rapidly from the mouth and throat to reach therapeutic concentrations.
Q: Does Dobendan Strepsils interact with any herbal supplements?
Specific herbal supplements are not listed in the regulatory interaction tables. However, official warnings advise caution with any concomitant product that might increase the risk of gastrointestinal ulceration or bleeding, which is a general risk associated with NSAIDs.
Q: Does Dobendan Strepsils contain gluten?
Some versions contain wheat starch as an excipient. Regulatory documents state that the resulting gluten levels are considered very low, making them generally suitable for those with coeliac disease. Patients with a known wheat allergy should verify the specific product ingredients.
Q: Are there any special considerations for older adults using this product?
Yes. Official warnings advise that elderly patients are at an increased risk of serious adverse reactions, especially gastrointestinal bleeding and perforation, when using NSAIDs like Flurbiprofen. Caution is required, as noted in the product's safety information.
Q: Can Dobendan Strepsils be used for irritation that isn't caused by an infection?
Yes. The product is indicated for the local short-term symptomatic relief of sore throat which includes pain and irritation. This relief is provided for symptoms, regardless of whether the irritation is caused by an infection or another factor.
Q: Do official safety documents mention any risks for individuals with liver or kidney conditions?
Yes. The Flurbiprofen lozenge is contraindicated in patients with severe renal insufficiency or severe hepatic insufficiency. Caution is required for those with less severe liver or kidney impairment.
Q: Are there any official warnings about taking the medicine long-term?
Yes. The product is indicated for short-term use only and the regulatory warning states use should not exceed 3 days. Prolonged use of the NSAID component is associated with an increased risk of cardiovascular and gastrointestinal adverse events.
Q: How is the research on Dobendan Strepsils generally funded or conducted?
Clinical efficacy data found in the regulatory documents are derived from clinical trials, such as randomized controlled studies. These studies are typically conducted by the manufacturer or by independent institutions under the sponsorship of the Marketing Authorisation Holder.
Q: What is the purpose of the various flavorings used in the lozenges?
The flavorings (like lemon or honey) are listed as excipients or inactive ingredients. Their primary purpose is to enhance taste and palatability, which encourages the user to dissolve the lozenge slowly and correctly for optimal local effect.
Q: Can people with diabetes use the sugar-free versions of Dobendan Strepsils?
Yes. The availability of sugar-free versions, which contain alternative sweeteners, means these specific products are intended to assist individuals who must limit sugar intake, such as those with diabetes.
Q: Are the inactive ingredients in Dobendan Strepsils known to cause issues?
Yes. Official product information lists warnings for certain inactive ingredients (excipients). These can include substances like specific colorings or sugars that are known to cause issues such as allergic reactions or are contraindicated in individuals with rare hereditary disorders.
Q: Can this product cause changes in taste perception?
Yes. Changes in taste perception, known as dysgeusia, are listed as an uncommon undesirable effect in the official safety profile for the Flurbiprofen lozenge.
Q: Do any official documents list interactions between Dobendan Strepsils and alcohol?
Regulatory documents for the Flurbiprofen lozenge advise that alcohol should be avoided during treatment. This is due to the potential for alcohol to increase the risk of gastrointestinal bleeding, which is an associated risk with NSAIDs.
